195 related articles for article (PubMed ID: 26774363)
1. Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer.
Nohara S; Kato K; Fujiwara D; Sakuragi N; Yanagihara K; Iwanuma Y; Kajiyama Y
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):494-503. PubMed ID: 26774363
[TBL] [Abstract][Full Text] [Related]
2. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
[TBL] [Abstract][Full Text] [Related]
3. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
5. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
[TBL] [Abstract][Full Text] [Related]
7. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
[TBL] [Abstract][Full Text] [Related]
9. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
10. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
[TBL] [Abstract][Full Text] [Related]
13. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
14. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
Tamaki R; Kanai-Mori A; Morishige Y; Koike A; Yanagihara K; Amano F
Oncol Rep; 2017 Apr; 37(4):2366-2374. PubMed ID: 28260018
[TBL] [Abstract][Full Text] [Related]
16. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
[TBL] [Abstract][Full Text] [Related]
17. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M
Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452
[TBL] [Abstract][Full Text] [Related]
18. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
19. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Toshiyama R; Konno M; Eguchi H; Takemoto H; Noda T; Asai A; Koseki J; Haraguchi N; Ueda Y; Matsushita K; Asukai K; Ohashi T; Iwagami Y; Yamada D; Sakai D; Asaoka T; Kudo T; Kawamoto K; Gotoh K; Kobayashi S; Satoh T; Doki Y; Nishiyama N; Mori M; Ishii H
Oncogene; 2019 Jan; 38(2):244-260. PubMed ID: 30089817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
